Beryl Drugs raises Aminova related party transaction limit to ₹8 crore

scanx
Reviewed by
Suketu GScanX News Team
Key Highlights
  • Beryl Drugs raised material RPT limit with Aminova Infusions to ₹8 crore
  • Previous limit for related party transactions was ₹5 crore
  • AGM adopted FY26 audited financial statements and reappointed Sudhir Sethi
powered bylight_fuzz_icon
52208581

*this image is generated using AI for illustrative purposes only.

Beryl Drugs Limited shareholders approved an increase in the limit for material related party transactions with Aminova Infusions Private Limited from ₹5.00 crore to ₹8.00 crore. This resolution was passed during the 33rd Annual General Meeting held on September 29, 2026.

The meeting also adopted the audited financial statements for the fiscal year ended March 31, 2026, and approved the reappointment of Sudhir Sethi as a director. The session took place at Kanchan Palace, Community Hall, Nipania Ring Road, Indore, commencing at 11:00 am and concluding at 11:30 am.

Key resolutions passed

The shareholders considered and approved three primary items on the agenda:

  • Adoption of the audited financial statements, including the Balance Sheet, Statement of Profit & Loss, and Cash Flow statement for FY26.
  • Reappointment of Sudhir Sethi (DIN: 00090172) as a retiring director.
  • Increase in the limit of material related party transactions with Aminova Infusions Private Limited.

Details on related party transaction approval

The revised limit of ₹8.00 crore constitutes the overall ceiling for transactions covered under the existing approval granted by members at the Extraordinary General Meeting held on May 11, 2026. This increase applies to the unexpired period of that original approval, which had a tenure of two years.

The company clarified that this is not an additional ₹8.00 crore limit over and above transactions already undertaken pursuant to the earlier approval. All other terms and conditions, nature of transactions, and tenure parameters remain unchanged. The transactions continue to be undertaken in the ordinary course of business on an arm's length basis, subject to the Companies Act, 2013, and SEBI Listing Regulations.

Historical Stock Returns for Beryl Drugs

1 Day5 Days1 Month6 Months1 Year5 Years
+6.15%+6.23%+10.78%+37.99%+13.40%+76.32%

What specific operational drivers or supply chain expansions prompted Beryl Drugs to increase its related party transaction limit with Aminova Infusions by 60%?

How might the increased reliance on Aminova Infusions impact Beryl Drugs' negotiating leverage and cost structure in future procurement cycles?

Will the higher transaction ceiling lead to increased scrutiny from SEBI regarding the arm's length pricing of these related party deals?

Beryl Drugs schedules 33rd AGM for September 29, 2026 in Indore

scanx
Reviewed by
Riya DScanX News Team
Key Highlights
  • Beryl Drugs Limited will hold its 33rd AGM on September 29, 2026, in Indore
  • Share transfer books remain closed from September 23 to September 29, 2026
  • Remote e-voting is open from September 26 to September 28, 2026
  • Shareholders must hold shares as of the September 22, 2026 cut-off date
powered bylight_fuzz_icon
50182624

*this image is generated using AI for illustrative purposes only.

Beryl Drugs Limited has scheduled its 33rd Annual General Meeting for Tuesday, September 29, 2026. The meeting will take place at Kanchan Palace Community Hall in Indore to transact business outlined in the notice dispatched on September 3, 2026.

The company will close its register of members and share transfer books from September 23 to September 29, 2026, inclusive. This closure determines shareholder eligibility for voting and dividend entitlements.

E-Voting Details

Shareholders holding shares as of the cut-off date of September 22, 2026, may cast their votes electronically. The remote e-voting window opens on September 26, 2026, at 9:00 am and closes on September 28, 2026, at 5:00 pm. The Central Depository Services Limited (CDSL) will disable the e-voting module after this period.

Parameter Detail
Meeting Date September 29, 2026
Time 11:00 am
Venue Kanchan Palace, Indore
Book Closure September 23–29, 2026
Record Date September 22, 2026
E-Voting Window Sept 26 (9:00 am) – Sept 28 (5:00 pm)

The results of the e-voting, along with the Scrutinizer's Report, will be announced on or after the AGM and posted on the company's website. The Annual Report for the financial year ended March 31, 2026, is available alongside the notice on the company's digital platforms.

Historical Stock Returns for Beryl Drugs

1 Day5 Days1 Month6 Months1 Year5 Years
+6.15%+6.23%+10.78%+37.99%+13.40%+76.32%

What specific resolutions regarding dividend payouts or capital allocation are likely to be proposed at the upcoming AGM?

How might the outcomes of the AGM influence Beryl Drugs' strategic direction for the fiscal year ending March 2027?

Are there any anticipated changes in board composition or executive compensation that shareholders should monitor during the voting process?

More News on Beryl Drugs

1 Year Returns:+13.40%